This effectively means that HUL brands like Horlicks and Boost will now fall ... especially those for diabetes and women's health, are selling better. Hindustan Unilever has renamed its 'health ...
GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...